Literature DB >> 33823251

WILD Sheath Technique: "WIre Loop Directional" Sheath for Retrograde Femoral Access in Branched Endovascular Aortic Aneurysm Repair.

Vassilios Zymvragoudakis1, Tommaso Donati2, Panos Gkoutzios3, Said Abisi2.   

Abstract

Branched endovascular aortic aneurysm repair (BEVAR) necessitates upper limb access (ULA) to facilitate the antegrade cannulation of downward directional branches and the placement of the bridging stent grafts. Various technical solutions to avoid ULA have been proposed and successfully applied in a limited number of cases. This can be necessary in specific clinical scenarios such as hostile aortic arch and descending thoracic aortic anatomy, or in the case of previous aortic arch and supra-aortic vessels surgery complicating the conventional approach with ULA in BEVAR. Taking inspiration from the prior description of a precursory technique, we report the application of our technique in BEVAR procedures, using standard introducer sheaths as a directional stable platform to facilitate an "All Femoral Access" (AFA) approach without the need for ULA, snaring or commercial steerable sheaths. Our concept is based on utilizing a wire loop to form a directional sheath (WILD sheath technique).
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endovascular aortic repair; WILD sheath technique; branched stent-graft; endograft; femoral access; retrograde access; steerable sheath; thoracoabdominal aortic aneurysm

Mesh:

Year:  2021        PMID: 33823251     DOI: 10.1016/j.avsg.2021.03.013

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  1 in total

1.  Use of a Steerable Sheath for Completely Femoral Access in Branched Endovascular Aortic Repair Compared to Upper Extremity Access.

Authors:  Sven R Hauck; Wolf Eilenberg; Alexander Kupferthaler; Maximilian Kern; Theresa-Marie Dachs; Alexander Wressnegger; Christoph Neumayer; Christian Loewe; Martin A Funovics
Journal:  Cardiovasc Intervent Radiol       Date:  2022-04-07       Impact factor: 2.797

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.